At-Home Molecular Testing Market Revenue is Expected to Reach US$16.3 Billion by the end of 2030, By Persistence Market Research
17 janv. 2024 00h58 HE
|
Persistence Market Research
New York, Jan. 17, 2024 (GLOBE NEWSWIRE) -- At-Home Molecular Testing Market: A Booming Frontier in Healthcare At-Home Molecular Testing refers to the use of molecular diagnostic tests conducted in...
P23 Health E-Commerce Well-Being Company Just Launched in Partnership With P23 Labs, a Renowned Molecular Laboratory
03 nov. 2022 09h15 HE
|
P23 Health
SAVANNAH, Ga., Nov. 03, 2022 (GLOBE NEWSWIRE) -- P23 Health is a newly formed digital healthcare and wellness company under the P23 umbrella. P23 Health's strategic partner is acknowledged molecular...
MAKO Medical Invests in New Laboratory Automation
18 juil. 2022 07h10 HE
|
MAKO Medical
RALEIGH, N.C., July 18, 2022 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and national leader in COVID-19 testing, is purchasing four additional high-tech liquid...
Genetic Testing Market is projected to reach USD 36.11 Billion by 2030, growing at a CAGR of 10%: Straits Research
16 juin 2022 15h40 HE
|
Straits Research
New York, United States, June 16, 2022 (GLOBE NEWSWIRE) -- Genetic testing examines DNA to find gene mutations linked to a wide range of hereditary illnesses. There are multiple forms of genetic...
Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipio’s HemeScreen POL Offering by Q4-2021
26 avr. 2021 11h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 26, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that currently, the contracted annualized revenues from signed customers...
Precipio Signs Sales & Marketing Agreement for HemeScreen™ with Major Oncology Distributor
10 déc. 2020 10h15 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with a major US-based oncology distributor to...
Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation
25 avr. 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
Pennsylvania and Connecticut Labs Both Receive Accreditation PARSIPPANY, NJ, April 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has...
Interpace Diagnostics Announces New York State Approval
23 avr. 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
State of New York Approves Commercialization of ThyraMIR® Now in Three Specimens PARSIPPANY, NJ, April 23, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today...
In-vitro Diagnostic Services Market worth over $63 billion by 2024: Global Market Insights, Inc.
13 sept. 2018 06h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Global In-vitro Diagnostic Services Market is poised to cross USD 63 billion by 2024; according to a new research report by Global Market...
IASLC邀請肺癌專業人士參加環球分子診斷調查
12 juil. 2018 16h11 HE
|
IASLC
丹佛, July 13, 2018 (GLOBE NEWSWIRE) -- 國際肺癌研究協會（IASLC）鼓勵所有參與肺癌患者分子診斷的人員參加一項環球調查，本調查旨在評估最佳實務的實施情况及最終制定分子診斷的環球指引。欲參加IASLC肺癌分子診斷環球調查，請瀏覽www.iaslc.org/survey。 IASLC的醫學博士、哲學博士和執行長Fred R....